http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011111435-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c81509f724183ee7d0ac72cf258bb347 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
filingDate | 2009-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a81b5f2a1041452c794a114139f51dcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba5da82c5e2d894e26a3ffb29a24f2ff |
publicationDate | 2011-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2011111435-A |
titleOfInvention | Neuroblastoma or glioblastoma treatment |
abstract | Neuroblastoma and / or glioblastoma therapeutic agent, neuroblastoma and / or glioblastoma diagnostic agent and diagnostic kit, neuroblastoma and / or glioblastoma based on novel mechanism of action A risk factor diagnostic agent and diagnostic kit, and a screening method for a substance relating to an active ingredient of a therapeutic or prophylactic agent for neuroblastoma and / or glioblastoma are provided. The drug of the present invention contains a substance that inhibits the function of the YB-1 gene and / or YB-1 protein as an active ingredient, thereby enabling neuroblastoma and glial based on a novel mechanism of action. It can be used effectively for the treatment of blastoma. In addition, neuroblastoma and / or glioblastoma, and their risk factors can be diagnosed by measuring YB-1 gene expression or YB-1 production, or the effect on these, as an index. In addition, a substance relating to an active ingredient of a preventive or therapeutic agent for neuroblastoma and / or glioblastoma can be screened. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104946597-A |
priorityDate | 2009-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 215.